About: http://webisa.webdatacommons.org/113356570

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	That could be very useful, given the competitive pressures that Amgen has seen from Teva and others against its Aranesp and Epogen treatment for kidney disease related to cancer and other conditions.
http://www.w3.org/ns/prov#wasQuotedFrom	fool.com